Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient

被引:45
作者
Bernal-Cano, F.
Joseph, J. T.
Koralnik, I. J. [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02115 USA
关键词
aIDS; demyelination; HIV; immunosupression; JC virus; multiple; sclerosis; progressive multifocal leukoencephalopathy; spinal cord;
D O I
10.1080/13550280701469178
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Progressive multifocal leukoencephalopathy (PML) is a deadly demyelinating disease of the central nervous system, which occurs in immunosuppressed individuals. This disease is caused by a reactivation of the polyomavirus JC (JCV). Clinical presentation can be variable from patient to patient as lesions can occur anywhere in the CNS white matter; however, they appear to spare the optic nerves and the spinal cord. The authors present a case of PML in the setting of acquired immunodeficiency syndrome (AIDS) who developed PML lesions in the spinal cord, discovered during the postmortem examination. This finding is significant because PML has recently been diagnosed in patients with multiple sclerosis (MS) treated with the novel immunomodulatory medication natalizumab. Indeed, spinal cord lesions are frequent in MS. Therefore clinicians should be aware that in addition to the brain, PML may also affect the spinal cord white matter.
引用
收藏
页码:474 / 476
页数:3
相关论文
共 8 条
[1]  
BAUER W, 1969, NEUROLOGY, V18, P287
[2]   Progressive multifocal leukoencephalopathy and natalizumab - Unforeseen consequences [J].
Berger, JR ;
Koralnik, IJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04) :414-416
[3]   Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis [J].
Kleinschmidt-DeMasters, BK ;
Tyler, KL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04) :369-374
[4]   Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? [J].
Koralnik, Igor J. .
ANNALS OF NEUROLOGY, 2006, 60 (02) :162-173
[5]   Brief report - Progressive multifocal leukoencephalopathy in a patient treated with natalizumab [J].
Langer-Gould, A ;
Atlas, SW ;
Green, AJ ;
Bollen, AW ;
Pelletier, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04) :375-381
[6]   Infection with JC virus and possible dysplastic ganglion-like transformation of the cerebral cortical neurons in a case of progressive multifocal leukoencephalopathy [J].
Shintaku, M ;
Matsumoto, R ;
Sawa, H ;
Nagashima, K .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (10) :921-929
[7]  
VONEINSIEDEL RW, 1993, J NEUROL, V240, P391
[8]   Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy [J].
Weber, T ;
Trebst, C ;
Frye, S ;
Cinque, P ;
Vago, L ;
Sindic, CJM ;
SchulzSchaeffer, WJ ;
Kretzschmar, HA ;
Enzensberger, W ;
Hunsmann, G ;
Luke, W .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (01) :250-254